Core Viewpoint - The document outlines the fundraising management system of Anhui Huaheng Biotechnology Co., Ltd., emphasizing the importance of proper management, usage, and supervision of raised funds to enhance efficiency and effectiveness in line with national policies and regulations [2][3]. Fundraising Management - The company must ensure that raised funds are used exclusively for designated purposes, primarily in main business areas that enhance competitiveness and innovation [2][3]. - The board of directors is responsible for monitoring the management and usage of raised funds to prevent investment risks and ensure safety [3][4]. - Related parties, including major shareholders and actual controllers, are prohibited from misusing the raised funds for personal gain [3][4]. Fund Storage and Usage - Raised funds must be stored in a dedicated account approved by the board of directors, and a tripartite supervision agreement must be signed with the financial advisor and the bank within one month of fund receipt [4][5]. - The company is required to use the raised funds according to the investment plan outlined in the issuance application documents, and any significant deviations must be promptly disclosed [5][6]. Project Management - The company must establish project management systems to monitor the application of funds, project progress, and quality [6][7]. - If a project faces significant changes in market conditions or delays, the company must reassess its feasibility and disclose the findings [6][7]. Cash Management - Temporarily idle raised funds can be managed through cash management products, which must be safe and liquid, with specific conditions outlined [8][9]. - Any temporary use of raised funds for working capital must be approved by the board and disclosed [9][10]. Use of Excess Funds - Excess funds must be allocated to ongoing or new projects, or for share repurchases, with a clear plan disclosed to shareholders [10][11]. - Any changes in the use of raised funds must be approved by the board and disclosed, ensuring that new projects align with the company's main business [12][13]. Reporting and Supervision - The company must provide accurate and complete disclosures regarding the actual use of raised funds, including any significant impacts on investment plans [26][27]. - An annual report must include verification from accounting firms regarding the management and usage of raised funds [14][15].
华恒生物: 募集资金管理制度(2025年9月修订)